Thoratec Price Tag May Be Too High for Medtronic, Abbott

Thoratec Corp. may appeal to other suitors, but the rich price tag will probably keep them at bay.

The maker of implants that aid failing hearts has 30 days to search for a better offer than the $63.50 a share in cash that St. Jude Medical Inc. has agreed to pay. Thoratec shares closed on Wednesday at $63.46 in New York, which means investors aren’t counting on the so-called go-shop period being fruitful.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC